EGM
ACOR

Engineers Gate Manager’s Acorda Therapeutics ACOR Stock Holding History

Engineers Gate Manager’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-52
Closed -$207K – 1025
2015
Q2 		$207K Buy
+52
New +$201K 0.02% 911

Other funds holding ACOR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Engineers Gate Manager's ACOR Position: Q3 2015 in Review

Engineers Gate Manager sold out of Acorda Therapeutics (ACOR) in Q3 2015, closing a stake of 52 shares — an estimated $207K sold.

Engineers Gate Manager first reported a position in ACOR in Q2 2015 and held it in 1 quarter. The position peaked at $207K in Q2 2015. 176 funds tracked by Wall St. Rank hold ACOR as of Q3 2015.

  • Engineers Gate Manager reported no remaining Acorda Therapeutics position as of Q3 2015 after selling out during the quarter.
  • Engineers Gate Manager sold 52 Acorda Therapeutics shares in Q3 2015, an estimated $207K.
  • Engineers Gate Manager first reported a position in Acorda Therapeutics in Q2 2015 and held it in 1 quarter.
  • Engineers Gate Manager's Acorda Therapeutics position peaked at $207K in Q2 2015.
  • 176 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q3 2015.

Based on Engineers Gate Manager's 13F filing for Q3 2015, filed 16 Nov 2015.